{"id":528978,"date":"2026-07-02T07:57:09","date_gmt":"2026-07-02T07:57:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/528978\/"},"modified":"2026-07-02T07:57:09","modified_gmt":"2026-07-02T07:57:09","slug":"this-asx-healthcare-stock-is-jumping-15-today-heres-why","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/528978\/","title":{"rendered":"This ASX healthcare stock is jumping 15% today. Here\u2019s why"},"content":{"rendered":"

Imricor Medical Systems Inc (ASX: IMR<\/a>) shares are racing higher on Thursday after the company released an update that has excited investors.\u00a0<\/p>\n

At the time of writing, the ASX healthcare stock is up 15.24% to $2.08.<\/p>\n

That adds to a much better run in 2026, with the share price now up around 36% since January.<\/p>\n

The latest gain is tied to Imricor’s MRI-guided medical technology, which has been a key part of its US plans.<\/p>\n

It is still early days, but today’s announcement gives shareholders a better idea of how the US opportunity may build from here.\u00a0<\/p>\n

Let’s take a look.\u00a0<\/p>\n

\"Male<\/p>\n

Image source: Getty Images<\/p>\n

FDA clearance gives Imricor a lift<\/p>\n

According to the release<\/a>, Imricor has received FDA 510(k) clearance to expand the labelling for its NorthStar system to include pediatric use.\u00a0<\/p>\n

This means the US Food and Drug Administration has reviewed the device and is comfortable that it is similar enough to another product already sold in the country.\u00a0<\/p>\n

The company also received the same clearance for its Vision-MR Diagnostic Catheter.<\/p>\n

Essentially, both products can now be marketed for use in children, as well as adults, in the United States.\u00a0<\/p>\n

This follows the FDA clearance<\/a> Imricor received in January for adult patients, with the company submitting the pediatric label expansion<\/a> in April.\u00a0<\/p>\n

A new US pathway opens up<\/p>\n

Imricor’s technology lets doctors carry out some procedures inside an MRI scanner.<\/p>\n

That means they do not need to rely as much on X-ray equipment, which can expose patients and hospital staff to radiation.\u00a0<\/p>\n

The new clearance means Imricor’s technology can now be used in children for MRI-guided procedures, including cardiac catheterisations.\u00a0<\/p>\n

That could be useful for young patients, especially if they need more than one procedure over time.<\/p>\n

Imricor said more than 250,000 diagnostic right and left heart catheterisations are performed each year in the US across adult and children’s hospitals.<\/p>\n

The company sees diagnostic procedures as another possible market for NorthStar, which helps guide doctors during MRI-based procedures.\u00a0<\/p>\n

Why investors are looking further ahead<\/p>\n

Imricor believes the pediatric market could become an early entry point for NorthStar and its Vision-MR Diagnostic Catheter.\u00a0<\/p>\n

That’s because children’s hospitals may have a stronger reason to look at technology that reduces radiation exposure during procedures.<\/p>\n

If hospitals start adopting the system, it could help Imricor build a stronger base in the United States before pushing deeper into the adult market.<\/p>\n

Chair and CEO Steve Wedan said the company wants to help doctors and patients move away from radiation-heavy procedures where possible.\u00a0<\/p>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Imricor Medical Systems Inc (ASX: IMR) shares are racing higher on Thursday after the company released an update…\n","protected":false},"author":2,"featured_media":528979,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[103,397,396,61,60],"class_list":["post-528978","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/528978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=528978"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/528978\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/528979"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=528978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=528978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=528978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}